SEYLTX

Lisa Kammerman is a former FDA Master Reviewer and industry executive with 30+ years of experience in biostatistics and regulatory strategy. She spent 24 years at the FDA and later held leadership roles at AstraZeneca, bringing deep insight into both sides of drug development.

Now the founder of Kammerman Consulting, Lisa advises emerging pharma and biotech companies on statistical aspects of FDA strategy, protocol design, PROs, and regulatory submissions. Known for her integrity and scientific rigor, she’s especially skilled at helping teams avoid regulatory missteps and accelerate time to approval.

Lisa is also a classical musician, professional photographer, and advocate for children with special needs.